IR Releases
We will keep you informed. Here you will find our (ad-hoc-) releases for investors.
2025
* IR Release is only available in German.
To the press release "Mitglieder der apoBank erhalten sechs Prozent Dividende"
To the press release "Mitglieder der apoBank erhalten sechs Prozent Dividende"
02.04.2025 - Deutsche Apotheker- und Ärztebank (apoBank) ended fiscal 2024 with a stable net profit (after tax) of €96.0 million (2023: €94.2 million).
To the Annual Financial Report 2024
To the Annual Financial Report 2024
2024
28.08.2024 - Deutsche Apotheker- und Ärztebank (apoBank) generated a net profit after tax of €47.8 million.
To the Interim Report 2024
To the Interim Report 2024
11.04.2024 - Deutsche Apotheker- und Ärztebank (apoBank) ended fiscal 2023 with an increase in net profit to €94.2 million (2022: €65.8 million).
To the Annual financial report 2023
To the Annual financial report 2023
2023
30.08.2023 - Deutsche Apotheker- und Ärztebank (apoBank) generated a net profit after tax of €33.0 million in the first half of 2023 (30 June 2022: €32.8 million).
To the Interim Report 2023
To the Interim Report 2023
17.04.2023
* IR Release is only available in German.
To the IR Release "Zwei neue Vorstandsmitglieder ernannt"
* IR Release is only available in German.
To the IR Release "Zwei neue Vorstandsmitglieder ernannt"
30.03.2023 - Deutsche Apotheker- und Ärztebank (apoBank) closed financial 2022 with a stable net profit of €65.8 million, compared to €65.4 billion in 2021.
To the Annual Financial Report 2022
To the Annual Financial Report 2022
12.01.2023
* IR Release is only available in German.
To the IR Release "Veränderung im Vorstandsressort Großkunden und Märkte"
* IR Release is only available in German.
To the IR Release "Veränderung im Vorstandsressort Großkunden und Märkte"
2022
15.11.2022
* IR Release is only available in German.
To the IR Release "Veränderung im Vorstandsressort Finanzen und IT"
* IR Release is only available in German.
To the IR Release "Veränderung im Vorstandsressort Finanzen und IT"
30.09.2022
* IR Release is only available in German.
To the IR Release "Veränderungen im Vorstandsressort Risiko"
* IR Release is only available in German.
To the IR Release "Veränderungen im Vorstandsressort Risiko"
13.09.2022
* IR Release is only available in German.
To the IR Release "Veränderungen im Vorstandsressort Privatkunden"
* IR Release is only available in German.
To the IR Release "Veränderungen im Vorstandsressort Privatkunden"
30.08.2022 - Deutsche Apotheker- und Ärztebank (apoBank) generated a net profit after tax of €32.8 million (30 June 2021: €37.0 million) in the first half of 2022.
To the Interim Report 2022
To the Interim Report 2022
07.04.2022 - Deutsche Apotheker- und Ärztebank (apoBank) closed financial 2021 with a stable net profit of €65.4 million, compared to €65.3 million in 2020.
To the Annual Financial Report 2021
To the Annual Financial Report 2021
21.01.2022
* IR Release is only available in German.
To the IR Release "Neuer Vorstandsvorsitzender"
* IR Release is only available in German.
To the IR Release "Neuer Vorstandsvorsitzender"
2021
31.08.2021 - Deutsche Apotheker- und Ärztebank (apoBank) completed the first six months of 2021 with a net profit of €37.0 million (30 June 2020: €32.7 million).
To the Interim Report 2021
To the Interim Report 2021
30.04.2021
* IR Release is only available in German.
To the IR Release "Veränderungen im Vorstand Vertreterversammlung 2021"
* IR Release is only available in German.
To the IR Release "Veränderungen im Vorstand Vertreterversammlung 2021"
15.04.2021 - Deutsche Apotheker- und Ärztebank (apoBank) closed financial 2020 with a stable net profit of €65.3 million compared to €64.1 million in 2019.
More
More
Financial Key Data
Ratings apoBank
Information pursuant to WpPG
Bond Issuance
